| 查看: 516 | 回复: 2 | ||
[求助]
求助美国药典38，Factor IX Complex 3434的标准 已有2人参与
|
| 求助美国药典38，Factor IX Complex 3434的标准。 |
回复此楼» 猜你喜欢
生活琐事由它去
已经有4人回复
-
提交了我也来说说感想
已经有12人回复
-
青B发送上会通知了吗
已经有9人回复
-
西安交大新媒学院副院长用撤稿论文结题
已经有6人回复
-
论文撤稿了
已经有8人回复
-
博士申请
已经有7人回复
-
化学专业申博
已经有4人回复
-
河北省自然科学基金
已经有9人回复
-
某211大学教师把个人教师官方主页改成:我跑了我跑了我跑了!官宣跑路！
已经有5人回复
-
26/27申博自荐
已经有9人回复
orionwei
至尊木虫 (著名写手)
- 应助: 25 (小学生)
- 金币: 23566.7
- 帖子: 1990
- 在线: 243.8小时
- 虫号: 311310
- 注册: 2006-12-26
- 性别: GG
- 专业: 药物分析
【答案】应助回帖
|
Factor IX Complex (fak' tor). » Factor IX Complex conforms to the regulations of the federal Food and Drug Administration concerning biologics (see Biologics 1041 ). It is a sterile, freeze-dried powder consisting of partially purified Factor IX fraction, as well as concentrated Factors II, VII, and X fractions, of venous plasma obtained from healthy human donors. It contains no preservative. It meets the requirements of the test for potency in having not less than 80 percent and not more than 120 percent of the potency stated on the label in Factor IX Units by comparison with the U.S. Factor IX Standard or with a working reference that has been calibrated with it. Packaging and storage— Preserve in hermetic containers in a refrigerator. Expiration date— The expiration date is not later than 2 years from the date of manufacture. Labeling— Label it with a warning that it is to be used within 4 hours after constitution, and to state that it is for intravenous administration and that a filter is to be used in the administration equipment. Auxiliary Information— Please check for your question in the FAQs before contacting USP. Topic/Question Contact Expert Committee Monograph Anita Y. Szajek, Ph.D. Principal Scientific Liaison (301) 816-8325 (BIO22010) Monographs - Biologics and Biotechnology 2 USP38–NF33 Page 3434 |
2楼2015-10-09 12:14:39
min1986
金虫 (小有名气)
- 应助: 37 (小学生)
- 金币: 1131.3
- 散金: 5
- 红花: 6
- 帖子: 189
- 在线: 74.4小时
- 虫号: 854383
- 注册: 2009-09-22
- 专业: 药物分析
【答案】应助回帖
| 看看是不是这个东东~~~~~~~~~~ |
» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : Factor_IX_Complex.pdf
2015-11-04 15:09:06, 21.04 K
3楼2015-11-04 15:09:07